| CXSB2300020 | 培集成干扰素α-2注射液 | Peginterferon alfacon-2 | Injection | Biological Products | Supplementary Application | 2023-02-25 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHS0508053 | 注射用三磷酸胞苷二钠 | cytidine disodium triphosphate | Lyophilized | Chemical Drugs(6) | Generic Drug | 2005-12-08 | | Beijing Kawin Technology Share-Holding Co Ltd | In Review | 2008-04-23 | view |
| CYSB2200184 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products | Supplementary Application | 2022-07-28 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB0503622 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2006-02-07 | | Beijing Kawin Technology Share-Holding Co Ltd | In Review | 2008-04-23 | view |
| CYHB2101716 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2021-08-23 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHS0508052 | 注射用三磷酸胞苷二钠 | cytidine disodium triphosphate | Lyophilized | Chemical Drugs(6) | Generic Drug | 2005-12-08 | | Beijing Kawin Technology Share-Holding Co Ltd | In Review | 2008-04-23 | view |
| CYHB2101717 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2021-08-23 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB0503621 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2006-02-07 | | Beijing Kawin Technology Share-Holding Co Ltd | In Review | 2008-04-23 | view |
| CXSL2400018 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products(2.2) | New Drug Application | 2024-01-10 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB0502580 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2005-11-03 | | Beijing Kawin Technology Share-Holding Co Ltd | In Review | 2008-04-23 | view |
| CYHB2250441 | 复方甘草酸苷片 | Glycyrrhizin;Glycine;DL-Methionine | Tablet | Chemical Drugs(原6) | Supplementary Application | 2022-07-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2300038 | KW-027注射液 | KW-027 | Injection | Biological Products(1) | New Drug Application | 2023-01-13 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2200464 | 培集成干扰素α-2注射液 | Peginterferon alfacon-2 | Injection | Biological Products(2.2) | New Drug Application | 2022-09-16 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB0503620 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2006-02-07 | | Beijing Kawin Technology Share-Holding Co Ltd | In Review | 2008-04-23 | view |
| CXSL2400016 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products(2.2) | New Drug Application | 2024-01-09 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB0502581 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2005-11-03 | | Beijing Kawin Technology Share-Holding Co Ltd | In Review | 2008-04-23 | view |
| CXSL2200459 | 人干扰素α2b喷雾剂 | Recombinant Human Interferon α2b | Spray | Biological Products(2.2) | New Drug Application | 2022-09-14 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB2101715 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2021-08-23 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYSB2200225 | 培集成干扰素α-2注射液 | Peginterferon alfacon-2 | Injection | Biological Products | Supplementary Application | 2022-09-09 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2300345 | 培集成干扰素α-2注射液 | Peginterferon alfacon-2 | Injection | Biological Products(2.2) | New Drug Application | 2023-05-17 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
